Literature DB >> 216678

Early effect of progesterone on levels of cyclic adenosine 3':5'-monophosphate in Xenopus oocytes.

J L Maller, F R Butcher, E G Krebs.   

Abstract

Progesterone treatment of Xenopus oocytes in vitro causes progression through meiotic cell division. The role of altered intracellular levels of cAMP on the initiation of meiotic cell division has been studied. Basal levels of cAMP averaged 1.5 pmol in oocytes from eight females, and exposure to progesterone caused a rapid drop in cAMP to about 40 to 60% of basal. Half-maximal decreases occurred within 15 to 60 s, and cAMP returned to near basal values by 20 min after progesterone. Theophylline inhibition of progesterone-induced cell division was characterized by a small increase in basal levels of cAMP and a reduced drop in cAMP due to the hormone. Cholera toxin, an activator of adenylate cyclase, was found to be a potent inhibitor of progesterone-induced meiosis, with half-maximal inhibition at 8 times 10(-12) M. In addition, the purified A subunit of cholera toxin was an effective inhibitor of progesterone action when microinjected into oocytes, with half-maximal inhibition occurring at an approximate internal concentration of 1 X 10(-7) M. Cholera toxin alone increased cAMP levels by 20%, but upon addition of progesterone, the level increased transiently to 200% of basal, indicating that the inhibition was due to elevated levels of cAMP. The results support a model in which the initiation of meiotic cell division is regulated by cAMP and protein phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 216678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Pioneering the Xenopus oocyte and egg extract system.

Authors:  James L Maller
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

2.  Ha-rasVal-12,Thr-59 activates S6 kinase and p34cdc2 kinase in Xenopus oocytes: evidence for c-mosxe-dependent and -independent pathways.

Authors:  C B Barrett; R M Schroetke; F A Van der Hoorn; S K Nordeen; J L Maller
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

3.  Intracellular signals trigger ultrastructural events characteristic of meiotic maturation in oocytes of Xenopus laevis.

Authors:  W M Bement; D G Capco
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

4.  Role of calcium in the localization of maternal poly(A)+RNA and tubulin mRNA in Xenopus oocytes.

Authors:  Carolyn A Larabell; David G Capco
Journal:  Rouxs Arch Dev Biol       Date:  1988-05

5.  Cyclic adenosine monophosphate, calcium, acetylcholine and the current induced by adenosine in the Xenopus oocyte.

Authors:  J Stinnakre; C Van Renterghem
Journal:  J Physiol       Date:  1986-05       Impact factor: 5.182

6.  G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.

Authors:  Brian C Duckworth; Jennifer S Weaver; Joan V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

7.  The greatwall kinase is dominant over PKA in controlling the antagonistic function of ARPP19 in Xenopus oocytes.

Authors:  Aude-Isabelle Dupré; Olivier Haccard; Catherine Jessus
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

8.  Increased phosphorylation of ribosomal protein S6 during meiotic maturation of Xenopus oocytes.

Authors:  P J Nielsen; G Thomas; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  A role for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the maintenance of meiotic arrest in Xenopus laevis oocytes.

Authors:  Diana Ríos-Cardona; Roberto R Ricardo-González; Ajay Chawla; James E Ferrell
Journal:  Dev Biol       Date:  2008-03-07       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.